http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2454979-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6588bb493ce7a0e22e1cb9548464505e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aea31a4a8dd337c8750fe01e1aa5b89d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e2dead25f883a9aa67bed2b42e3268f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfbd85e42ffd922963ccc204e90f5958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0e57faf46d805515a2e18d00d66f658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc1bf6097357e15951ca786477095f91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39d16eeafc91072e4906502dc75db6cb
publicationDate 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2454979-C1
titleOfInvention Method of drainage surgery of secondary glaucoma with rubeosis in patients with diabetes mellitus
abstract FIELD: method. n SUBSTANCE: invention relates to medicine, namely to ophthalmology and is intended for drainage surgery of secondary glaucoma with rubeosis. 1-3 days before surgery in area of planned colobomas delimiting coagulation by diode laser is performed on iris of eye, with wavelength 532 nm. In the course of operation after taking superior rectus muscle on bridle suture, 2 paracenteses are performed in places of delimiting coagulation, approximately 0.5 ml of intraocular fluid are discharged, 2 colobomas of iris are performed through paracenteses. Valve drainage is installed into subtenon space. Before the installation of valve into subtenon space and on valve itself endothelium protector is applied, valve is fixed by 2 interrupted sutures 8-0 by special holes in valve body for more reliable fixation. In anterior chamber through paracentesis silicone tube is installed for 2-3 mm, U-shaped scleral flap is fixed on edges by two interrupted sutures 8-0, sutures are applied on conjunctiva. n EFFECT: method makes it possible to reduce quantity of intra- and post-operative complications, reduce intraocular pressure, reduce quantity of painful sensations. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2691315-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2662147-C1
priorityDate 2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448241444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID410087

Total number of triples: 20.